Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Man Study of Pulsed Field Ablation System for the Treatment of Paroxysmal Atrial Fibrillation in 1 Patient

NCT07452211 is registered in ClinicalTrials.gov with Hangzhou Dinova EP Technology Co., Ltd as lead sponsor.

NCT NCT07452211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07452211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Man Study of Pulsed Field Ablation System for the Treatment of Paroxysmal Atrial Fibrillation in 1 Patient
Lead sponsor
Hangzhou Dinova EP Technology Co., Ltd
Phase
Not applicable
Overall status
Completed
Start date
December 18, 2020
Completion date
April 10, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation (paf)